Repository Corticotropin Injection in Keratoconjunctivitis Sicca

首次发布于 2018 年 1 月 12 日

Safety and Efficacy Study of CF101 to Treat Keratoconjunctivitis Sicca

计划入组 80 人 · 首次发布于 2006 年 7 月 7 日

Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca

计划入组 745 人 · 首次发布于 2016 年 2 月 23 日

anti-DNA virus program (epidemic keratoconjunctivitis)

EKC-Cide

Lodoxamide(Alomide)

C₁₁H₆ClN₃O₆ · Rx

Q4 2025 Biotech Catalyst Monitor Identifies 20 Key Pipeline Events Including Cytokinetics' Aficamten and GSK's Depemokimab

Dompé Initiates Phase 3 Trial of Dual-Mechanism Isocyclosporin for Atopic Keratoconjunctivitis

Harrow Re-Launches VERKAZIA, First FDA-Approved Steroid-Sparing Therapy for Vernal Keratoconjunctivitis